Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 400 W ERIE ST SUITE 110 CHICAGO IL 60654 |
Tel: | N/A |
Website: | https://www.crescolabs.com |
IR: | See website |
Key People | ||
Gregory Butler President | Charles Bachtell Chief Executive Officer, Director | Dennis M. Olis Chief Financial Officer |
Ty Gent Chief Operating Officer | Zach Marburger Chief Information Officer | John P. Schetz General Counsel |
Angie Demchenko Chief People Officer | Jason Bennett Erkes Chief Communications Officer |
Business Overview |
Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs' national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy's. Its portfolio consists of over 400 products. The Company's products are sold in over 1,600 dispensaries across the country. Its Cresco offers consistent strains, available in a variety of product forms at dispensaries and retail locations nationwide. Its High Supply lab-tested; and available in vape carts, vape pens, flower, popcorn, shake, shorties and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Its Mindy's offers dosed edibles created by James Beard. It is the wholesaler of branded cannabis products. |
Financial Overview |
For the fiscal year ended 31 December 2023, Cresco Labs Inc revenues decreased 9% to $770.9M. Net loss decreased 17% to $175.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Selling, General and Administration Bal decrease of 39% to $56.6M (expense), Salaries and Related decrease of 10% to $141.2M (expense). |
Employees: | 2,760 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $1,708M as of Dec 31, 2023 |
Annual revenue (TTM): | $1,056M as of Dec 31, 2023 |
EBITDA (TTM): | $172.74M as of Dec 31, 2023 |
Net annual income (TTM): | -$240.47M as of Dec 31, 2023 |
Free cash flow (TTM): | $0.93M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $793.68M as of Dec 31, 2023 |
Shares outstanding: | 439,577,512 as of Mar 5, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |